California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing | Vanderbilt Health News
NEW31 days ago|Discuss (0)|Health
Article written by Bill Snyder
Vanderbilt Health has developed human monoclonal antibodies that effectively neutralize the measles virus and have been licensed by Saravir Biopharma for further development and testing. The antibodies address an urgent need for alternative treatments due to rising measles cases linked to declining vaccination rates.
Read full story @ news.vumc.org/2026/09/28/california-firm-licenses-potent-anti-measles-antibodies-from-vanderbilt-health-for-development-clinical-testing »
NewzGrade: 93 [A]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
93A
FDCBA
SPAG95
Coherent90
Objective95
Sourced100
Concise85
Graded by NewzGrade AI AI · provisional on September 28, 2026 at 04:03 PM
93A
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 95 | 100 | 85 |
93Agrade breakdown
SPAG
95
Coherent
90
Objective
95
Sourced
100
Concise
85
The article meets high journalistic standards for news writing, presenting unbiased information backed by credible sources, though it contains some complex ideas that could be clearer.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
